Deutsche Bank raised the firm’s price target on Tenet Healthcare to $126 from $100 and keeps a Buy rating on the shares. Since its lows in October, the stock has rallied 92%, the analyst tells investors in a research note. The firm increased the price target after analyzing the impact on revenue and EBITDA from the hospital sales and how that plays out across 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Spotify initiated, Lowe’s downgraded: Wall Street’s top analyst calls
- Tenet Healthcare upgraded to Outperform from Peer Perform at Wolfe Research
- Tenet Healthcare price target raised to $110 from $100 at Mizuho
- Barclays starts health care facilities, managed care group with Neutral view
- Tenet Healthcare initiated with an Overweight at Barclays
